Olszewska-Slonina Dorota, Jung Stanislaw, Matewski Dariusz, Olszewski Krzysztof J, Krzyzynska-Malinowska Ewa, Braszkiewicz Andrzej, Kowaliszyn Bogna
Department of Pathobiochemistry and Clinical Chemistry, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun , Bydgoszcz , Poland.
Scand J Clin Lab Invest. 2015 Apr;75(2):145-51. doi: 10.3109/00365513.2014.992946. Epub 2015 Jan 16.
To assess the activity of arylsulfatase (AS), acid phosphatase (ACP), cathepsin D (CAT-D) and alpha-1 antitrypsin (AAT) in blood serum and synovial fluid (SF) of patients with hip or knee osteoarthritis (OA).
The study included 43 subjects with OA (35 hip OA, 8 knee OA), submitted total joint replacement. The control group consisted of 58 subjects with no past history of musculoskeletal disorders.
The OA blood serum samples showed a significantly higher level of lysosomal enzymes activity than in the control group (AS by 17.8%, AAT by 42.4%); only the CAT-D activity decreased by 50%). AS, ACP and CAT-D activities were about two-fold higher in SF when compared with blood of OA patients. The differences between the genders were visible in the SF: Total protein concentration, activity of ACP (both higher in OA men) and activity of CAT-D (higher in OA women). Between the involved hip and knee, there were no significant differences in all estimated parameters in the blood serum of the OA group. In regard to the SF, only ACP activity was significantly higher in patients with a hip involved.
The osteoarthritic SF enzymatic profile differs from that in normal joints. The OA in joints is not reflected in the systemic response. Our preliminary results suggest further studies on role of lysosomal enzymes (ACP and AS) as biomarkers for the detection of osteoarthritis.
评估髋或膝骨关节炎(OA)患者血清和滑液(SF)中芳基硫酸酯酶(AS)、酸性磷酸酶(ACP)、组织蛋白酶D(CAT-D)和α-1抗胰蛋白酶(AAT)的活性。
该研究纳入43例接受全关节置换的OA患者(35例髋OA,8例膝OA)。对照组由58例无肌肉骨骼疾病病史的受试者组成。
OA患者血清样本中溶酶体酶活性水平显著高于对照组(AS升高17.8%,AAT升高42.4%);仅CAT-D活性降低了50%。与OA患者的血液相比,SF中AS、ACP和CAT-D的活性约高两倍。SF中可见性别差异:总蛋白浓度、ACP活性(OA男性均较高)和CAT-D活性(OA女性较高)。在OA组血清中,受累的髋和膝之间,所有评估参数均无显著差异。对于SF,仅受累髋部患者的ACP活性显著较高。
骨关节炎SF酶谱与正常关节不同。关节中的OA未反映在全身反应中。我们的初步结果表明,需进一步研究溶酶体酶(ACP和AS)作为骨关节炎检测生物标志物的作用。